Skip to main content
. 2020 May 6:10.2106/JBJS.20.00686. doi: 10.2106/JBJS.20.00686

TABLE III.

Clinical Parameters on Presentation

Variable Total Survivor Non-Survivor P Value* Mortality Rate per Variable
COVID-19 testing 136 123 13 0.001
 Positive 23 (16.9%) 16 (13%) 7 (53.8%) 30.4%
 Negative 39 (28.7%) 35 (28.5%) 4 (30.8%) 10.3%
 Not tested 74 (54.4%) 72 (58.5%) 2 (15.4%) 2.7%
Cough on presentation 123 113 10 0.008
 Yes 15 (12.2%) 11 (9.7%) 4 (40%) 26.7%
 No 108 (87.8%) 102 (90.3%) 6 (60%) 5.6%
Lobar consolidation on chest radiograph 135 122 13 0.016
 Yes 18 (13.3%) 13 (10.7%) 5 (38.5%) 27.8%
 No 117 (86.7%) 109 (89.3%) 8 (61.5%) 6.8%
White blood cell count in 1 µL of blood
 No. of patients 135 122 13
 Mean and standard deviation (µL) 2,713 ± 3,485 2,755 ± 3,591 2,314 ± 2,323 0.666
Serum creatinine levels in blood
 No. of patients 114 104 10
 Mean and standard deviation (mg/dL) 1.19 ± 0.73 1.19 ± 0.75 1.26 ± 0.57 0.794
*

The p values were calculated by the Mann-Whitney U test, chi-square test, or Fisher exact test, as appropriate.

The values are given as the number of patients, with or without the percentage in parentheses.

Data were missing for some patients.